Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 15, 2024

BUY
$26.88 - $83.49 $11.1 Million - $34.6 Million
414,207 New
414,207 $34.6 Million
Q4 2023

Feb 12, 2024

SELL
$26.88 - $83.49 $11.5 Million - $35.8 Million
-429,021 Reduced 50.88%
414,207 $34.6 Million
Q2 2023

Aug 14, 2023

BUY
$32.62 - $40.75 $16 Million - $19.9 Million
489,432 Added 138.34%
843,228 $27.5 Million
Q1 2023

May 11, 2023

SELL
$33.36 - $45.71 $5.18 Million - $7.09 Million
-155,134 Reduced 30.48%
353,796 $12.5 Million
Q4 2022

Feb 13, 2023

BUY
$35.77 - $51.11 $6.73 Million - $9.62 Million
188,208 Added 58.68%
508,930 $23.3 Million
Q3 2022

Nov 08, 2022

SELL
$38.54 - $54.52 $2,235 - $3,162
-58 Reduced 0.02%
320,722 $15.5 Million
Q2 2022

Aug 15, 2022

BUY
$33.93 - $48.92 $8.75 Million - $12.6 Million
257,836 Added 409.63%
320,780 $12.6 Million
Q1 2022

May 16, 2022

SELL
$29.74 - $46.0 $11.9 Million - $18.5 Million
-401,422 Reduced 86.45%
62,944 $2.32 Million
Q4 2021

Feb 14, 2022

BUY
$34.35 - $46.38 $1.3 Million - $1.75 Million
37,734 Added 8.84%
464,366 $21.2 Million
Q3 2021

Nov 15, 2021

SELL
$18.54 - $35.74 $1.01 Million - $1.95 Million
-54,691 Reduced 11.36%
426,632 $15.2 Million
Q2 2021

Aug 16, 2021

BUY
$19.79 - $26.99 $1.81 Million - $2.47 Million
91,603 Added 23.5%
481,323 $9.53 Million
Q1 2021

May 14, 2021

SELL
$18.57 - $25.68 $2.2 Million - $3.05 Million
-118,674 Reduced 23.34%
389,720 $9.07 Million
Q4 2020

Feb 16, 2021

BUY
$15.26 - $28.61 $2.43 Million - $4.55 Million
159,098 Added 45.55%
508,394 $10.6 Million
Q3 2020

Nov 13, 2020

BUY
$20.58 - $28.96 $3.89 Million - $5.48 Million
189,079 Added 118.01%
349,296 $7.56 Million
Q2 2020

Aug 13, 2020

BUY
$11.15 - $24.64 $1.79 Million - $3.95 Million
160,217 New
160,217 $3.78 Million
Q4 2019

Feb 14, 2020

SELL
$7.95 - $11.84 $1.68 Million - $2.5 Million
-210,992 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$10.82 - $14.25 $2.28 Million - $3.01 Million
210,992 New
210,992 $2.4 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.62B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.